Functional Genetics mission is to create and maintain a focus on product development. The company is seeking partners to support its discovery and product development initiatives. A number of out-licensing opportunities are available.
We have assembled a team of outstanding and productive partners in Industry, Academia and the Government. FGI has announced corporate partnerships with Elanco (a division of Eli Lilly & Company) and Evolva SA. Our collaborative partners in Academia have included The University of California, San Francisco, The University of Washington, Stanford University and the University of New Mexico. The Company also has productive collaborations with non-corporate organizations, including the National Institute of Allergy and Infectious Diseases (NIAID), the United States Army Medical Research Institute for Infectious Diseases (USAMRIID), the Centers for Disease Control and Prevention (CDC) and the Walter Reed Army Institute of Research (WRAIR).
Functional Genetics’ unique drug development approach has been recognized through grant and contract funding by the National Institutes of Health (NIAID), the Transformation Medical Technologies Initiative (TMTI) of the Defense Threat Reduction Agency (DTRA) and the Defense Advanced Research Projects Agency (DARPA).
